Antiinflammatory role of endomorphins in osteoarthritis, rheumatoid arthritis, and adjuvant-induced polyarthritis

Arthritis and Rheumatism

Volumn 58, Issue 2, 2008, Pages 456-466

  Straub, Rainer H ^a   Wolff, Christine ^a   Fassold, Alexander ^a   Hofbauer, Rafael ^a   Chover Gonzalez, Antonio ^b   Richards, Louise J ^c   Jessop, David S ^c  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF CÁDIZ   (Spain)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOMORPHIN 1; ENDOMORPHIN 2; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NONHUMAN; OSTEOARTHRITIS; POLYARTHRITIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RHEUMATOID ARTHRITIS; SPLEEN; STAINING; SYNOVIUM; T LYMPHOCYTE; THYMUS; TISSUE PERFUSION;

AGED; ARTHRITIS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; OLIGOPEPTIDES; OSTEOARTHRITIS; SYNOVIAL MEMBRANE;

EID: 39749155759     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23206     Document Type: Article

References (57)

1. Schaible HG, Grubb BD. Afferent and spinal mechanisms of joint pain [review]. Pain 1993;55:5-54.
2. Levine JD, Clark R, Devor M, Helms C, Moskowitz MA, Basbauni AI. Intraneuronal substance P contributes to the severity of experimental arthritis. Science 1984;226:547-9.
3. Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988;241:1218-21.
4. Brenn D, Richter F, Schaible HG. Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat: an inflammatory mechanism of joint pain. Arthritis Rheum 2006;56:351-9.
5. Puehler W, Stein C. Controlling pain by influencing neurogenic pathways [review]. Rheum Dis Clin North Am 2005;31:103-13, ix.
6. Helyes Z. Role of peripheral μ-opioid receptors in arthritis: are they potential targets for therapy? Arthritis Rheum 2005;52: 2955-9.
7. Levine JD, Fields HL, Basbaum AI. Peptides and the primary afferent nociceptor [review]. J Neurosci 1993;13:2273-86.
8. Stein C, Hassan AH, Przewlocki R, Gramsch C, Peter K, Herz A. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci U S A 1990;87:5935-9.
9. Mudge AW, Leeman SE, Fischbach GD. Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration. Proc Natl Acad Sci U S A 1979;76:526-30.
10. Holzer P. Characterization of the stimulus-induced release of immunoreactive substance P from the myenteric plexus of the guinea-pig small intestine. Brain Res 1984;297:127-36.
11. Eisenstein TK, Hilburger ME. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J Neuroimmunol 1998;83:36-44.
12. Philippe D, Dubuquoy L, Groux H, Brun V, Chuoi-Mariot MT, Gaveriaux-Ruff C, et al. Anti-inflammatory properties of the μ opioid receptor support its use in the treatment of colon inflammation. J Clin Invest 2003;111:1329-38.
13. Stein A, Yassouridis A, Szopko C, Helmke K, Stein C. Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 1999;83:525-32.
14. Zadina JE, Hackler L, Ge LJ, Kastin AJ. A potent and selective endogenous agonist for the μ-opiate receptor. Nature 1997;386: 499-502.
15. Jessop DS. Endomorphins as agents for the treatment of chronic inflammatory disease. BioDrugs 2006;20:161-6.
16. Li Z, Proud D, Zhang C, Wiehler S, McDougall JJ. Chronic arthritis down-regulates peripheral μ-opioid receptor expression with concomitant loss of endomorphin 1 antinociception. Arthritis Rheum 2005;52:3210-9.
17. McDougall JJ, Barin AK, McDougall CM. Loss of vasomotor responsiveness to the μ-opioid receptor ligand endomorphin-1 in adjuvant monoarthritic rat knee joints. Am J Physiol Regul Integr Comp Physiol 2004;286:R634-41.
18. Han Z, Jiang YH, Wan Y, Wang Y, Chang JK, Han JS. Endomorphin-1 mediates 2 Hz but not 100 Hz electroacupuncture analgesia in the rat. Neurosci Lett 1999;274:75-8.
19. Labuz D, Berger S, Mousa SA, Zollner C, Rittner HL, Shaqura MA, et al. Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain. J Neurosci 2006;26:4350-8.
20. Khalil Z, Sanderson K, Modig M, Nyberg F. Modulation of peripheral inflammation by locally administered endomorphin-1. Inflamm Res 1999;48:550-6.
21. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
22. Jessop DS, Major GN, Coventry TL, Kaye SJ, Fulford AJ, Harbuz MS, et al. Novel opioid peptides endomorphin-1 and endomorphin-2 are present in mammalian immune tissues. J Neuroimmunol 2000;106:53-9.
23. Miller LE, Weidler C, Falk W, Angele P, Schaumburger J, Scholmerich J, et al. Increased prevalence of semaphorin 3C, a repellent of sympathetic nerve fibers, in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 2004;50:1156-63.
24. Straub RH, Herrmann M, Frauenholz T, Berkmiller G, Lang B, Scholmerich J, et al. Neuroimmune control of interleukin-6 secretion in the murine spleen: differential adrenergic effects of electrically released endogenous norepinephrine under various endotoxin conditions. J Neuroimmunol 1996;71:37-43.
25. Straub RH, Herrmann M, Berkmiller G, Frauenholz T, Lang B, Scholmerich J, et al. Neuronal regulation of interleukin 6 secretion in murine spleen: adrenergic and opioidergic control. J Neurochem 1997;68:1633-9.
26. Denko CW, Aponte J, Gabriel P, Petricevic M. β-endorphin, immunological and biochemical changes in synovial fluid in rheumatic disorders. Clin Rheumatol 1986;5:25-32.
27. Gronblad M, Konttinen YT, Korkala O, Liesi P, Hukkanen M, Polak JM. Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1988;15:1807-10.
28. Elhassan AM, Adem A, Lindgren JU. Met-enkephalin decreases in adjuvant arthritic ankles. J Rheumatol 1998;25:1953-6.
29. Yoshino S, Koiwa M, Shiga H, Nakamura H, Higaki M, Miyasaka N. Detection of opioid peptides in synovial tissues of patients with rheumatoid arthritis. J Rheumatol 1992;19:660-1.
30. Bender T, Barna I, Geher P. Synovial immunoreactive β-endorphin levels in rheumatoid arthritis and osteoarthritis [letter]. Clin Exp Rheumatol 1999;17:630.
31. Calza L, Pozza M, Arletti R, Manzini E, Hokfelt T. Long-lasting regulation of galanin, opioid, and other peptides in dorsal root ganglia and spinal cord during experimental polyarthritis. Exp Neurol 2000;164:333-43.
32. Persson S, Schafer MK, Nohr D, Ekstrom G, Post C, Nyberg F, et al. Spinal prodynorphin gene expression in collagen-induced arthritis: influence of the glucocorticosteroid budesonide. Neuroscience 1994;63:313-26.
33. Kar S, Gibson SJ, Rees RG, Jura WG, Brewerton DA, Polak JM. Increased calcitonin gene-related peptide (CGRP), substance P, and enkephalin immunoreactivities in dorsal spinal cord and loss of CGRP-immunoreactive motoneurons in arthritic rats depend on intact peripheral nerve supply. J Mol Neurosci 1991;3:7-18.
34. Weihe E, Millan MJ, Leibold A, Nohr D, Herz A. Co-localization of proenkephalin- and prodynorphin-derived opioid peptides in laminae IV/V spinal neurons revealed in arthritic rats. Neurosci Lett 1988;85:187-92.
35. Bourgoin S, Le BD, Clot AM, Hamon M, Cesselin F. Spontaneous and evoked release of met-enkephalin-like material from the spinal cord of arthritic rats in vivo. Pain 1988;32:107-14.
36. Panerai AE, Sacerdote P, Bianchi M, Brini A, Mantegazza P. Brain and spinal cord neuropeptides in adjuvant induced arthritis in rats. Life Sci 1987;41:1297-303.
37. Hollt V, Haarmann I, Millan MJ, Herz A. Prodynorphin gene expression is enhanced in the spinal cord of chronic arthritic rats. Neurosci Lett 1987;73:90-4.
38. Przewlocki R, Lason W, Silberring J, Herz A, Przewlocka B. Release of opioid peptides from the spinal cord of rats subjected to chronic pain. NIDA Res Monogr 1986;75:422-5.
39. Shen H, Aeschlimann A, Reisch N, Gay RE, Simmen BR, Michel BA, et al. Kappa and delta opioid receptors are expressed but down-regulated in fibroblast-like synoviocytes of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 2005;52:1402-10.
40. Takeba Y, Suzuki N, Kaneko A, Asai T, Sakane T. Endorphin and enkephalin ameliorate excessive synovial cell functions in patients with rheumatoid arthritis. J Rheumatol 2001;28:2176-83.
41. Elvenes J, Andjelkov N, Figenschau Y, Seternes T, Bjorkoy G, Johansen O. Expression of functional μ-opioid receptors in human osteoarthritic cartilage and chondrocytes. Biochem Biophys Res Commun 2003;311:202-7.
42. Shaqura MA, Zollner C, Mousa SA, Stein C, Schafer M. Characterization of λ opioid receptor binding and G protein coupling in rat hypothalamus, spinal cord, and primary afferent neurons during inflammatory pain. J Pharmacol Exp Ther 2004;308:712-8.
43. Yin H, Yu M, Cheng H, Zhang F, Gao Y, Lin J, et al. β-endorphin prevents collagen induced arthritis by neuroimmuno-regulation pathway. Neuro Endocrinol Lett 2005;26:739-44.
44. Straub RH, Schaller T, Miller LE, von Horsten S, Jessop DS, Falk W, et al. Neuropeptide Y cotransmission with norepinephrine in the sympathetic nerve-macrophage interplay. J Neurochem 2000; 75:2464-71.
45. Heijnen CJ, Zijlstra J, Kavelaars A, Croiset G, Ballieux RE. Modulation of the immune response by POMC-derived peptides. I. Influence on proliferation of human lymphocytes. Brain Behav Immun 1987;1:284-91.
46. Williamson SA, Knight RA, Lightman SL, Hobbs JR. Effects of β endorphin on specific immune responses in man. Immunology 1988;65:47-51.
47. Pasnik J, Tchorzewski H, Baj Z, Luciak M, Tchorzewski M. Priming effect of met-enkephalin and β-endorphin on chemiluminescence, chemotaxis and CD11b molecule expression on human neutrophils in vitro. Immunol Lett 1999;67:77-83.
48. Szabo I, Wetzel MA, Zhang N, Steele AD, Kaminsky DE, Chen C, et al. Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization. J Leukoc Biol 2003;74:1074-82.
49. Miller LE, Justen HP, Scholmerich J, Straub RH. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J 2000;14:2097-107.
50. Miller LE, Grifka J, Scholmerich J, Straub RH. Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis. J Rheumatol 2002;29:427-35.
51. Marabini S, Matucci-Cerinic M, Geppetti P, Del BE, Marchesoni A, Tosi S, et al. Substance P and somatostatin levels in rheumatoid arthritis, osteoarthritis, and psoriatic arthritis synovial fluid. Ann N Y Acad Sci 1991;632:435-6.
52. Hernanz A, de Miguel E, Romera N, Perez-Ayala C, Gijon J, Arnalich F. Calcitonin gene-related peptide II, substance P and vasoactive intestinal peptide in plasma and synovial fluid from patients with inflammatory joint disease. Br J Rheumatol 1993;32: 31-5.
53. McDougall JJ, Baker CL, Hermann PM. Attenuation of knee joint inflammation by peripherally administered endomorphin-1. J Mol Neurosci 2004;22:125-37.
54. Narita M, Mizoguchi H, Oji GS, Tseng EL, Suganuma C, Nagase H, et al. Characterization of endomorphin-1 and -2 on [35S]GTPγS binding in the mouse spinal cord. Eur J Pharmacol 1998;351:383-7.
55. Sakurada S, Hayashi T, Yuhki M, Orito T, Zadina JE, Kastin AJ, et al. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse. Eur J Pharmacol 2001;427:203-10.
56. Wu HE, Mizoguchi H, Terashvili M, Leitermann RJ, Hung KC, Fujimoto JM, et al. Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of μ-opioid receptor clone leads to differential loss of spinal endomorphin-1- and endomorphin-2-induced antinociception in the mouse. J Pharmacol Exp Ther 2002;303:867-73.
57. Li ZH, Shan LD, Jiang XH, Guo SY, Yu GD, Hisamitsu T, et al. Analgesic effect of endomorphin-1. Acta Pharmacol Sin 2001;22:976-80.